<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> is the third and second most common <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> among men and women, respectively, in France </plain></SENT>
<SENT sid="1" pm="."><plain>Interest in the chemoprevention of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> has increased over the last two decades </plain></SENT>
<SENT sid="2" pm="."><plain>Experimental data strongly suggest that <z:chebi fb="1" ids="9907">ursodeoxycholic acid</z:chebi> (UDCA) may have chemopreventative actions in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>UDCA is able to inhibit <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> development in azoxymethane and in <z:chebi fb="0" ids="52071">dextran</z:chebi>-related <z:hpo ids='HP_0002583'>colitis</z:hpo> models </plain></SENT>
<SENT sid="4" pm="."><plain>In high-risk populations such as subjects with previous colorectal <z:mpath ids='MPATH_270'>adenoma</z:mpath> removal or <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e>, five out of 10 published studies suggested beneficial effects with UDCA on colonic <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>In the azoxymethane model, UDCA inhibited <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> development by counteracting the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-promoting effects of secondary <z:chebi fb="1" ids="3098">bile acids</z:chebi> such as <z:chebi fb="0" ids="28834">deoxycholic acid</z:chebi> (DCA) </plain></SENT>
<SENT sid="6" pm="."><plain>The opposing effects of UDCA and DCA on <z:chebi fb="23" ids="18059">lipid</z:chebi> raft composition may be central to their effects on colonic <z:mp ids='MP_0002006'>tumorigenesis</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>Differential effects of DCA and UDCA on growth factor and inflammatory signals involved in colorectal <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e>, such as epidermal growth factor receptor (EGFR) signaling and COX-2 expression, very likely mediate their opposing effects on <z:e sem="disease" ids="C0009375" disease_type="Neoplastic Process" abbrv="">colonic tumor</z:e> promotion and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> inhibition, respectively </plain></SENT>
</text></document>